Novartis invests $55m in US gene therapy site, prepares BLA – BioPharma-Reporter.com
BioPharma-Reporter.comNovartis invests $55m in US gene therapy site, prepares BLABioPharma-Reporter.comThe clinical-stage gene therapy firm will invest $55m into the site – located in Research Triangle Park, North Carolina, US – and add 200 jobs in eng… Continue reading
